Imaging Features of Patients Undergoing Active Surveillance for Ductal Carcinoma in Situ

Publication date: Available online 10 July 2017
Source:Academic Radiology
Author(s): Lars J. Grimm, Sujata V. Ghate, E. Shelley Hwang, Mary Scott Soo
Rationale and ObjectivesThe aim of this study was to describe the imaging appearance of patients undergoing active surveillance for ductal carcinoma in situ (DCIS).Materials and MethodsWe retrospectively identified 29 patients undergoing active surveillance for DCIS from 2009 to 2014. Twenty-two patients (group 1) refused surgery or were not surgical candidates. Seven patients (group 2) enrolled in a trial of letrozole and deferred surgical excision for 6–12 months. Pathology and imaging results at the initial biopsy and follow-up were recorded.ResultsIn group 1, the median follow-up was 2.7 years (range: 0.6–13.9 years). Fifteen patients (68%) remained stable. Seven patients (32%) underwent additional biopsies with invasive ductal carcinoma diagnosed in two patients after 3.9 and 3.6 years who developed increasing calcifications and new masses. In group 2, one patient (14%) was upstaged to microinvasive ductal carcinoma at surgery. Among the patients in both groups with calcifications (n = 26), there was no progression to invasive disease among those with stable (50%, 13/26) or decreased (19%, 5/26) calcifications.ConclusionsAmong a DCIS active surveillance cohort, invasive disease progression presented as increasing calcifications and a new mass following more than 3.5 years of stable imaging. In contrast, there was no progression to invasive disease among cases of DCIS with stable or decreasing calcifications. Close imaging is a key follow-up component in active surveillance.



http://ift.tt/2ucgQ3n